Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27814 | 220 | 22.3 | 47% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
27814 | 1 | FOSPHENYTOIN//PURPLE GLOVE SYNDROME//PHENYTOIN | 220 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FOSPHENYTOIN | authKW | 1112875 | 10% | 38% | 21 |
2 | PURPLE GLOVE SYNDROME | authKW | 693986 | 2% | 100% | 5 |
3 | PHENYTOIN | authKW | 305129 | 25% | 4% | 56 |
4 | FOSPHENYTOIN SODIUM | authKW | 277594 | 1% | 100% | 2 |
5 | GLUCOSE INFUSION FLUID | authKW | 277594 | 1% | 100% | 2 |
6 | 2 DIMENSIONAL NUCLEAR OVERHAUSER EFFECT SPECTROSCOPY | authKW | 138797 | 0% | 100% | 1 |
7 | ACC 9653 CEREBYX | authKW | 138797 | 0% | 100% | 1 |
8 | ASSOCIATIVE SPECIES | authKW | 138797 | 0% | 100% | 1 |
9 | BILA 2185 BS | authKW | 138797 | 0% | 100% | 1 |
10 | BRADYDYSRHYTHMIA | authKW | 138797 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1495 | 48% | 0% | 106 |
2 | Clinical Neurology | 440 | 20% | 0% | 45 |
3 | Emergency Medicine | 404 | 6% | 0% | 13 |
4 | Chemistry, Medicinal | 316 | 12% | 0% | 26 |
5 | Chemistry, Multidisciplinary | 63 | 14% | 0% | 30 |
6 | Pediatrics | 37 | 5% | 0% | 12 |
7 | Pathology | 17 | 3% | 0% | 7 |
8 | Literary Theory & Criticism | 15 | 0% | 0% | 1 |
9 | Literary Reviews | 14 | 0% | 0% | 1 |
10 | Anesthesiology | 13 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DERMATOPATHOL LMP 5031 | 138797 | 0% | 100% | 1 |
2 | KLIN INNERE MED ALLGEMEINE INNERE MED | 138797 | 0% | 100% | 1 |
3 | PHARM PHARMACEUT CHILD NEUROL | 138797 | 0% | 100% | 1 |
4 | PHARM SHANDS JACKSONVILLE | 138797 | 0% | 100% | 1 |
5 | SERV POLYVALENT ACCUEIL TRAITEMENT URGENCES | 138797 | 0% | 100% | 1 |
6 | BIOMEGA RECH | 69398 | 0% | 50% | 1 |
7 | NIHR ALDER HEY CLIN IL | 46264 | 0% | 33% | 1 |
8 | CNS CLIN DEV | 42703 | 1% | 15% | 2 |
9 | INT EPILEPSY | 37009 | 1% | 13% | 2 |
10 | DEV ITABASHI KU | 34698 | 0% | 25% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EVENT | 138797 | 0% | 100% | 1 |
2 | CLINICAL PHARMACY | 2891 | 2% | 1% | 4 |
3 | AMERICAN JOURNAL OF HOSPITAL PHARMACY | 2801 | 3% | 0% | 7 |
4 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 2251 | 2% | 0% | 5 |
5 | JOURNAL OF PHARMACOBIO-DYNAMICS | 2123 | 2% | 0% | 5 |
6 | EPILEPSIA | 1547 | 5% | 0% | 10 |
7 | JOURNAL OF PHARMACEUTICAL SCIENCES | 992 | 4% | 0% | 9 |
8 | CLINICAL PHARMACOKINETICS | 937 | 2% | 0% | 4 |
9 | FORMULARY | 924 | 1% | 0% | 2 |
10 | PEDIATRIC PHARMACOLOGY | 773 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FOSPHENYTOIN | 1112875 | 10% | 38% | 21 | Search FOSPHENYTOIN | Search FOSPHENYTOIN |
2 | PURPLE GLOVE SYNDROME | 693986 | 2% | 100% | 5 | Search PURPLE+GLOVE+SYNDROME | Search PURPLE+GLOVE+SYNDROME |
3 | PHENYTOIN | 305129 | 25% | 4% | 56 | Search PHENYTOIN | Search PHENYTOIN |
4 | FOSPHENYTOIN SODIUM | 277594 | 1% | 100% | 2 | Search FOSPHENYTOIN+SODIUM | Search FOSPHENYTOIN+SODIUM |
5 | GLUCOSE INFUSION FLUID | 277594 | 1% | 100% | 2 | Search GLUCOSE+INFUSION+FLUID | Search GLUCOSE+INFUSION+FLUID |
6 | 2 DIMENSIONAL NUCLEAR OVERHAUSER EFFECT SPECTROSCOPY | 138797 | 0% | 100% | 1 | Search 2+DIMENSIONAL+NUCLEAR+OVERHAUSER+EFFECT+SPECTROSCOPY | Search 2+DIMENSIONAL+NUCLEAR+OVERHAUSER+EFFECT+SPECTROSCOPY |
7 | ACC 9653 CEREBYX | 138797 | 0% | 100% | 1 | Search ACC+9653+CEREBYX | Search ACC+9653+CEREBYX |
8 | ASSOCIATIVE SPECIES | 138797 | 0% | 100% | 1 | Search ASSOCIATIVE+SPECIES | Search ASSOCIATIVE+SPECIES |
9 | BILA 2185 BS | 138797 | 0% | 100% | 1 | Search BILA+2185+BS | Search BILA+2185+BS |
10 | BRADYDYSRHYTHMIA | 138797 | 0% | 100% | 1 | Search BRADYDYSRHYTHMIA | Search BRADYDYSRHYTHMIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FISCHER, JH , PATEL, TV , FISCHER, PA , (2003) FOSPHENYTOIN - CLINICAL PHARMACOKINETICS AND COMPARATIVE ADVANTAGES IN THE ACUTE TREATMENT OF SEIZURES.CLINICAL PHARMACOKINETICS. VOL. 42. ISSUE 1. P. 33-58 | 39 | 46% | 40 |
2 | AARONSON, PM , BELGADO, BS , SPILLANE, JP , KUNISAKI, TA , (2011) EVALUATION OF INTRAMUSCULAR FOSPHENYTOIN VS INTRAVENOUS PHENYTOIN LOADING IN THE ED.AMERICAN JOURNAL OF EMERGENCY MEDICINE. VOL. 29. ISSUE 9. P. 983-988 | 17 | 85% | 1 |
3 | ARMSTRONG, EP , SAUER, KA , DOWNEY, MJ , (1999) PHENYTOIN AND FOSPHENYTOIN: A MODEL OF COST AND CLINICAL OUTCOMES.PHARMACOTHERAPY. VOL. 19. ISSUE 7. P. 844 -853 | 19 | 100% | 5 |
4 | SWADRON, SP , RUDIS, MI , AZIMIAN, K , BERINGER, P , FORT, D , ORLINSKY, M , (2004) A COMPARISON OF PHENYTOIN-LOADING TECHNIQUES IN THE EMERGENCY DEPARTMENT.ACADEMIC EMERGENCY MEDICINE. VOL. 11. ISSUE 3. P. 244-252 | 17 | 89% | 13 |
5 | MEEK, PD , DAVIS, SN , COLLINS, M , GIDAL, BE , RUTECKI, PA , BURSTEIN, AH , FISCHER, JH , LEPPIK, IE , RAMSAY, RE , (1999) GUIDELINES FOR NONEMERGENCY USE OF PARENTERAL PHENYTOIN PRODUCTS - PROCEEDINGS OF AN EXPERT PANEL CONSENSUS PROCESS.ARCHIVES OF INTERNAL MEDICINE. VOL. 159. ISSUE 22. P. 2639 -2644 | 24 | 73% | 17 |
6 | WARNECKE, IC , RAUTE-KREINSEN, U , SCHIRMER, S , KRETSCHMER, F , FANSA, H , (2010) PURPLE GLOVE SYNDROME - A CASE REPORT.HANDCHIRURGIE MIKROCHIRURGIE PLASTISCHE CHIRURGIE. VOL. 42. ISSUE 4. P. 260 -262 | 12 | 92% | 1 |
7 | COPLIN, WM , RHONEY, DH , REBUCK, JA , CLEMENTS, EA , COCHRAN, MS , O'NEILL, BJ , (2002) RANDOMIZED EVALUATION OF ADVERSE EVENTS AND LENGTH-OF-STAY WITH ROUTINE EMERGENCY DEPARTMENT USE OF PHENYTOIN OR FOSPHENYTOIN.NEUROLOGICAL RESEARCH. VOL. 24. ISSUE 8. P. 842-848 | 15 | 88% | 12 |
8 | STELLA, VJ , (1996) A CASE FOR PRODRUGS: FOSPHENYTOIN.ADVANCED DRUG DELIVERY REVIEWS. VOL. 19. ISSUE 2. P. 311-330 | 26 | 58% | 28 |
9 | GULDIKEN, B , REMI, J , NOACHTAR, S , (2016) CARDIOVASCULAR ADVERSE EFFECTS OF PHENYTOIN.JOURNAL OF NEUROLOGY. VOL. 263. ISSUE 5. P. 861 -870 | 19 | 42% | 0 |
10 | FIERRO, LS , SAVULICH, DH , BENEZRA, DA , (1996) SAFETY OF FOSPHENYTOIN SODIUM.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 53. ISSUE 22. P. 2707-2712 | 18 | 75% | 18 |
Classes with closest relation at Level 1 |